| abstract |
The present invention relates to β-glucan immunotherapy methods, and in one aspect, discloses a method for identifying β-glucan that binds to a subject's immune cells. Usually, the method of the present application is such that a blood sample comprising immune cells is obtained from a subject, soluble β-glucan is added to at least part of the blood sample, and soluble β-glucan can bind to immune cells. Incubating the mixture under as well as detecting soluble β-glucan bound to immune cells. In other embodiments, the application typically identifies the subject as a low binder of β-glucan and co-administers a soluble β-glucan to the subject and an antibody preparation capable of converting the subject from a low binder to a high binder. A method comprising: |